DAVITA INC. (NYSE:DVA) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
On June 16, 2017, the Company held its annual meeting of
stockholders in Denver, Colorado. Represented in person or by proxy
at the annual meeting were 163,364,597 shares of the Companys
common stock, or 83.94% of its outstanding shares of common stock.
The results of matters submitted to a stockholder vote at the
annual meeting are as follows:
stockholders in Denver, Colorado. Represented in person or by proxy
at the annual meeting were 163,364,597 shares of the Companys
common stock, or 83.94% of its outstanding shares of common stock.
The results of matters submitted to a stockholder vote at the
annual meeting are as follows:
Item 1. Election of Directors.
Eleven board nominees for director were elected by a majority of
the votes cast for a term of one year or until their successors are
duly elected and qualified. The voting results are as follows:
the votes cast for a term of one year or until their successors are
duly elected and qualified. The voting results are as follows:
|
|
|
|
|
|
|
|
|
|
|
Name of Nominee
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker non-votes
|
|
Pamela M. Arway
|
|
147,607,409
|
|
2,680,300
|
|
74,066
|
|
13,002,882
|
|
Charles G. Berg
|
|
146,762,396
|
|
3,528,879
|
|
70,500
|
|
13,002,882
|
|
Carol Anthony (John) Davidson
|
|
148,113,084
|
|
2,174,928
|
|
73,763
|
|
13,002,882
|
|
Barbara J. Desoer
|
|
150,061,192
|
|
230,767
|
|
69,816
|
|
13,002,882
|
|
Pascal Desroches
|
|
148,617,259
|
|
1,669,571
|
|
74,945
|
|
13,002,882
|
|
Paul J. Diaz
|
|
149,143,726
|
|
1,141,205
|
|
76,844
|
|
13,002,882
|
|
Peter T. Grauer
|
|
127,563,564
|
|
22,724,516
|
|
73,695
|
|
13,002,882
|
|
John M. Nehra
|
|
148,931,721
|
|
1,357,825
|
|
72,229
|
|
13,002,882
|
|
William L. Roper
|
|
148,307,970
|
|
1,983,042
|
|
70,763
|
|
13,002,882
|
|
Kent J. Thiry
|
|
143,719,862
|
|
5,290,648
|
|
1,351,265
|
|
13,002,882
|
|
Phyllis R. Yale
|
|
150,010,124
|
|
278,503
|
|
73,148
|
|
13,002,882
|
Item 2. Ratification of appointment of independent registered
public accounting firm.
public accounting firm.
The stockholders ratified the appointment of KPMG LLP as the
Company’s independent registered public accounting firm for 2017.
The voting results are as follows:
Company’s independent registered public accounting firm for 2017.
The voting results are as follows:
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
160,556,826
|
|
2,758,027
|
|
49,744
|
Item 3. Advisory vote on executive compensation.
The proposal received the vote of a majority of the shares
represented and entitled to vote at the meeting. The voting results
are as follows:
represented and entitled to vote at the meeting. The voting results
are as follows:
|
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker non-votes
|
|
142,027,373
|
|
8,198,566
|
|
135,836
|
|
13,002,882
|
Item 4. Advisory vote on the frequency of future advisory votes on
executive compensation
executive compensation
The proposal to hold future advisory votes on executive
compensation on an annual basis was approved. In light of these
results, the Company intends to continue holding an annual advisory
vote on executive compensation. The voting results are as follows:
compensation on an annual basis was approved. In light of these
results, the Company intends to continue holding an annual advisory
vote on executive compensation. The voting results are as follows:
|
|
|
|
|
|
|
|
|
1 Year
|
|
2 Years
|
|
3 Years
|
|
Abstain
|
|
135,726,613
|
|
115,737
|
|
14,399,382
|
|
120,043
|
About DAVITA INC. (NYSE:DVA)
DaVita Inc., formerly DaVita HealthCare Partners Inc., is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company’s Kidney Care division is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). HCP division is a patient and physician-focused integrated health care delivery and management company.
